Work

Sustained Long-term Safety and Tolerability of Foslevodopa/Foscarbidopa in Parkinson’s Disease: 96-week Primary Treatment Period Results from an Ongoing Open-label Extension Study (P11-5.006)

Year: 2025

Type: article

Source: Neurology

DOI: 10.1212/wnl.0000000000208722

Authors: Filip Bergquist, Jason Aldred, Erik Danielsen, Camille Carroll, Cheney Matthews, Jia Jia, Megha Shah, Amy Spiegel, Victor Fung

Institutions: University of Gothenburg, Aarhus University, University of Plymouth, AbbVie (United States), The University of Sydney

Language: English

Topic: Parkinson's Disease Mechanisms and Treatments

Subfield: Neurology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409222193

FWCI: 2.181

Cites:

Cited by: 4

Related to: 10